CareDx, Inc. (CDNA)

NasdaqGM • Currently down 0.74 (-1.13%) in today's trading session

1 member of Congress has disclosed 34 trades in CareDx, Inc. (CDNA) via STOCK Act filings. The most recent disclosure was a purchase by Tom Malinowski on 2 March 2021. Aggregate disclosed activity totals roughly $161K in purchases and $331.5K in sales (midpoint estimates from bracketed disclosure amounts).

CareDx, Inc. is currently trading at $64.69, positioned at 87% of its 52-week range ($14.03 – $72.51).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$64.69
24h Change
-0.74 (-1.13%)
52 Week Range
$14.03–$72.51
View on NASDAQ

CareDx, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CDNA

Select to highlight on chart
5 transactions
Compliance: 38%
Tom Malinowski2 Mar 202110 Apr 2021PurchaseStock$15,001 - $50,000N/A
Tom Malinowski2 Mar 202113 Aug 2022PurchaseStock$15,001 - $50,000N/A
Tom Malinowski11 Jan 202126 Aug 2021SaleStock$1,001 - $15,000N/A
Tom Malinowski11 Jan 202113 Aug 2022SaleStock$1,001 - $15,000N/A
Tom Malinowski8 Jan 202113 Aug 2022SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$3.35B

Volume

1.19M

Beta

2.38

P/E Ratio

77.01

Fundamentals

EPS

$0.84

Div. Yield

-

Open

$63.34

Day Range

$63.34 – $67.45

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
John Walter Hanna Jr.
IPO Date
2014-07-17

CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a ra...

Earnings

Next Report

Q3 2026

3 Nov

EPS Est.

$0.26

Rev. Est.

$122M

Days Until

19

Recent Quarters

Q2 202630 Jul
EPS$0.37
Beat 59.4%
Q1 202628 Apr
EPS$0.34
Beat 209.1%
Q4 202524 Feb
EPS$0.12
Beat 503.0%
Q3 20254 Nov
EPS$0.03
Beat 138.9%
Q2 20256 Aug
EPS$-0.16
Miss 66.0%
Q1 202530 Apr
EPS$-0.19
Beat 8.1%
Q4 202426 Feb
EPS$0.18
Beat 260.0%
Q3 20244 Nov
EPS$0.14
Beat 156.9%
Q2 202431 Jul
EPS$0.25
Beat 278.6%
Q1 20249 May
EPS$-0.03
Beat 85.7%
Q4 202328 Feb
EPS$-0.17
Beat 37.0%
Q3 20238 Nov
EPS$-0.18
Beat 55.0%
Q2 20238 Aug
EPS$-0.18
Beat 41.9%
Q1 202310 May
EPS$-0.11
Beat 0.0%
Q4 202227 Feb
EPS$-0.07
Beat 79.0%
Q3 20223 Nov
EPS$-0.06
Beat 57.1%
Q2 20224 Aug
EPS$-0.13
Miss 18.2%
Q1 20225 May
EPS$-0.13
Miss 160.0%
Q4 202124 Feb
EPS$-0.03
Miss 200.0%
Q3 202128 Oct
EPS$0.07
Beat 600.0%
Q2 202129 Jul
EPS$0.11
Beat 120.0%
Q1 20215 May
EPS$0.14
Beat 1500.0%
Q4 202024 Feb
EPS$0.08
Beat 300.0%
Q3 202029 Oct
EPS$0.10
Beat 350.0%
Q2 20204 Aug
EPS$0.04
Beat 200.0%
Q1 202030 Apr
EPS$-0.14
Miss 566.7%
Q4 201927 Feb
EPS$0.04
Beat 100.0%
Q3 201931 Oct
EPS$0.02
Beat 100.0%
Q2 20191 Aug
EPS$-0.19
Miss 65.2%
Q1 20198 May
EPS$0.05
Beat 266.7%
Q4 20186 Mar
EPS$0.01
Beat 0.0%
Q3 20188 Nov
EPS$-0.01
Beat 66.7%
Q2 20189 Aug
EPS$-0.04
Beat 42.9%
Q1 201810 May
EPS$-0.30
Miss 130.8%
Q4 201722 Mar
EPS$-0.09
Beat 30.8%
Q3 20179 Nov
EPS$-0.15
Beat 11.8%
Q2 201710 Aug
EPS$-0.17
Beat 10.5%
Q1 20179 Jun
EPS$-0.32
Miss 45.5%
Q1 201721 Apr
EPS$-0.13
Beat 23.5%
Q3 20169 Nov
EPS$-0.15
Beat 37.5%
Q2 201610 Aug
EPS$-0.29
Miss 3.6%
Q1 20166 May
EPS$-0.37
Miss 19.4%
Q4 201524 Mar
EPS$-0.37
Miss 8.8%
Q3 201511 Nov
EPS$-0.32
Miss 28.0%
Q2 201510 Aug
EPS$-0.26
Miss 44.4%
Q1 201512 May
EPS$-0.21
Miss 23.5%
Q4 201417 Mar
EPS$-0.00
Beat 99.6%
Q3 201410 Nov
EPS$0.01
Beat 107.7%
Q2 201427 Aug
EPS$-0.09
Beat 30.8%
Q4 201331 Mar
EPS$-0.12
Q3 201331 Dec
EPS$-0.08
Q2 201330 Sept
EPS$-0.11
Q1 201330 Jun
EPS$-0.11
Q4 201231 Mar
EPS$-0.18

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

CELC

Celcuity Inc.

47
$59.90-3.29 (-5.21%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

PCRX

Pacira BioSciences, Inc.

47
$36.40+0.09 (+0.25%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

TSLA

Tesla, Inc.

20
$367.16-8.07 (-2.15%)
Consumer Cyclical
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about CDNA

Which members of Congress have traded CDNA?
1 member of Congress has disclosed 34 trade in CareDx, Inc. (CDNA) under the STOCK Act: Tom Malinowski.
When was CDNA most recently disclosed by Congress?
The most recent CDNA disclosure was a purchase by Tom Malinowski on 2 March 2021.
What is the total disclosed congressional trading volume for CDNA?
Members of Congress have disclosed approximately $161K in CDNA purchases and $331.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in CDNA?
This CDNA page updates as soon as new STOCK Act disclosures are filed for CareDx, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.